Mandate

Vinge has advised Hexatronic Group AB (publ) in connection with a directed share issue

November 09, 2021 Capital Markets and Public M&A

Vinge has advised Hexatronic Group AB (publ) in connection with a directed share issue whereby the company receives approximately SEK 550 million in gross issue proceeds.

The share issue was carried out as an accelerated book building process and directed to selected Swedish and international institutional investors. Hexatronic intends to use the net proceeds from the directed share issue to increase Hexatronics financial flexibility for further acquisitions, to establish a new plant for micro duct production in the US that will be up and running in Q3 2022, for investments in increased production capacity based on high demand mostly from growth markets, and for general corporate purposes to support growth opportunities. ABG Sundal Collier AB and Pareto Securities AB acted as joint bookrunners in connection with the directed share issue. Vinge acted as legal adviser to Hexatronic.

Hexatronic Group AB (publ) is a group that develops, markets and delivers products, components and system solutions with the main focus on the fiber optic market, and offers a wide range of innovative system and product solutions mainly for passive fiber optic infrastructure.

Vinge’s team has consisted of Anders Strid, Edin Agic and Adrian Filipovic.

 

Related

Vinge advises Trianon in connection with directed share issue and tender offer for subordinated sustainable capital securities

Vinge advises Fastighets Aktiebolaget Trianon (publ) in connection with a directed share issue of SEK 184 million and a tender offer for outstanding subordinated perpetual floating rate callable sustainable capital securities.
April 19, 2024

Vinge advises Blackstone in connection with its investment in Winthrop Technologies

Vinge, as local Swedish counsel, advised Blackstone Tactical Opportunities and affiliated funds (“Blackstone”) in connection with a strategic partnership with Winthrop Technologies Limited (“Winthrop Technologies”).
April 17, 2024

Vinge has advised Hansa Biopharma in connection with a directed share issue of SEK 372 million

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of SEK 372 million before transaction costs. Hansa Biopharma is a commercial-stage biopharmaceutical company pioneering the development and commercialization of innovative, lifesaving and life altering treatments for patients with rare immunological conditions. Hansa Biopharma’s ordinary share is listed on Nasdaq Stockholm.
April 16, 2024